Transepithelial corneal cross-linking offers a new epi-on CXL protocol with biomechanical outcomes comparable to accelerated epi-off CXL for keratoconus treatment
New study reveals how accelerated PACK-CXL with riboflavin/UV-A or rose bengal/green light can be effective treatments for bacterial keratitis.
Monday, September 11th, 2023, at the ESCRS conference in Vienna, saw ELZA’s surgerons and researchers provide attendees with a series of presentations centered around advancements
Sunday, September 10th, 2023, continued the trend of informative presentations at the ESCRS 2023 conference in Vienna. Here’s a straightforward rundown of the day’s events:
Join us at #ESCRS2023 in Vienna! ELZA’s top surgeons & researchers will present the latest in ophthalmic treatments. Dive deep into innovation with us! ????????️ #ELZA at #ESCRS
The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can be accelerated while still maintaining its antibacterial efficacy. The study found that high-fluence PACK-CXL did indeed decrease the bacterial concentration of several clinically significant bacterial strains, including S. aureus, P. aeruginosa, and S. epidermidis. These strains are commonly implicated in bacterial keratitis and contact lens-associated keratitis. Furthermore, the authors found that higher total fluence PACK-CXL protocols led to a corresponding increase in bacterial killing ratio (BKR).
Can combining corneal OCT and air puff tonometry help better diagnose the earliest stages of keratoconus? That was the question ELZA researcher, Dr. Nanji Lu,
